Economists attributed this positive performance to the biotechnological company’s cost-cutting drive and an uptake in sales of its newly-launched Alzheimer’s drug, LEQEMBI. Analysts predicted that the sales of this treatment would be between $13mn and $30mn. Biogen’s Q1 sales of LEQEMBI, as noted by its Japanese partner, Eisai Co., Ltd. (4523.T), were $19mn. Don’t miss…
Read more
Revenue was reported at $42.78bn, which exceeded the $40.04bn that had been anticipated. In terms of earnings per share, $0.49 was also better than the estimated figure of $0.42. Net income of $1.3bn has been reported, and adjusted EBIT of $2.8bn. The Ford Pro commercial fleets division provided one of the most impressive returns, with revenue…
Read more
This is the weakest JPY/USD performance since the mid-1990s. All eyes are now on the Bank of Japan (BOJ) as the markets expect some intervention from this monetary policymaker to bolster the yen. Don’t miss out the latest news, subscribe to LeapRate’s newsletter This currency’s weakness sparked market angst as the Japanese finance minister, Shunichi…
Read more
The company’s better-than-expected results were said to be linked to increased credit card spending in the US, where Visa obtains over 40% of its overall global revenue. Adjusted net income for the quarter climbed by 17% to $5.1bn, working out as $2.51 per share. This was $0.07 better than the average analyst prediction. Don’t miss…
Read more
2023 saw Meta’s Reality Labs division lose $16bn, so CEO Mark Zuckerberg announced on Monday that it will be opening up the system so that other tech companies can make hardware using it. His announcement pointed out that Microsoft, ASUS and Lenovo are among the selected early partners that will be working with Meta on…
Read more
The users reportedly claim the gay dating app shared personal information, which included HIV statuses, with third parties. Law firm Austen Hays indicated it filed the lawsuit at the London High Court, alleging this could affect thousands of UK users. According to this filing, Austen Hays claims Grindr gave sensitive personal information to third parties…
Read more
This disappointing day followed a weak revenue forecast and confirmation that it will stop reporting subscriber numbers next year. Despite this fall, Netflix is still up 14% so far this year following a strong start to 2024. Expectations for the streaming giant’s Q1 results had been climbing recently, as analysts predicted excellent gains. When the…
Read more
The Norwegian sovereign wealth fund, one of the largest global investors, announced that its market value had increased to $1.6tn on Thursday, 18 April 2024. The fund further reported that most of its investments (72.1%) consisted of equities, 26% of fixed income, 1.8% of unlisted real estate, and 0.1% of renewable energy infrastructure. It reportedly…
Read more
The British oil giant said that it is streamlining its organisational framework to increase its value. Apart from Lin, who replaces Anja-Isabel Dotzenrath, the company also announced the appointment of Emeka Emembolu, who will be in charge of technology functions to replace Leigh-Ann Russell. CNBC reported that BP’s CEO, Murray Auchincloss, said: As I set…
Read more
The company markets this drug as Zepbound® in the US and as Mounjaro® in some international markets. These outcomes add to the merits of medicines such as Zepbound and Novo Nordisk’s (NVO) Ozempic in the treatment of obesity and diabetes. Despite supply, cost, and health insurance issues, these drugs remain in high demand worldwide. Lilly…
Read more